We are live on
!
Find out more
GG
Gleason Group Portfolio holdings
AUM
$1.15B
1-Year Est. Return
21.11%
This Fund
S&P 500
This Quarter
Est. Return
+15.09%
1 Year Est. Return
+21.11%
3 Year Est. Return
+63.97%
5 Year Est. Return
+59.1%
10 Year Est. Return
–
AUM
$208M
AUM Growth
+$35.2M
(+20%)
Cap. Flow
+$9.53M
Cap. Flow
% of AUM
4.57%
Top 10 Holdings %
Top 10 Hldgs %
77.24%
Holding
197
New
16
Increased
101
Reduced
18
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$2.99M |
| 2 |
Vanguard Total International Stock ETF
VXUS
|
+$1.92M |
| 3 |
Vanguard Extended Market ETF
VXF
|
+$1.85M |
| 4 |
Vanguard Total Stock Market ETF
VTI
|
+$968K |
| 5 |
Vanguard Value ETF
VTV
|
+$772K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Target
TGT
|
+$1.04M |
| 2 |
Johnson & Johnson
JNJ
|
+$228K |
| 3 |
Chevron
CVX
|
+$149K |
| 4 |
Intel
INTC
|
+$136K |
| 5 |
Procter & Gamble
PG
|
+$111K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.32% |
| 2 | Financials | 3.17% |
| 3 | Technology | 2.72% |
| 4 | Consumer Staples | 2.54% |
| 5 | Industrials | 2.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Navigator Holdings
NVGS
$1.28B
| $2K | ﹤0.01% |
200
| – | – |
|
|
ACB
177
Aurora Cannabis
ACB
$163M
| $1K | ﹤0.01% |
11
| – | – |
|
178
Delta Air Lines
DAL
$55.4B
| $1K | ﹤0.01% |
+17
| New | +$618 |
|
|
B
179
Barrick Mining
B
$58.5B
| $1K | ﹤0.01% |
41
| – | – |
|
|
PPL
180
PPL Corp
PPL
$27B
| $1K | ﹤0.01% |
+50
| New | +$1.42K |
|
181
iShares MSCI EAFE Small-Cap ETF
SCZ
$13.9B
| $1K | ﹤0.01% |
20
| – | – |
|
182
Tilray
TLRY
$531M
| $1K | ﹤0.01% |
9
| – | – |
|
183
Viatris
VTRS
$20.1B
| $1K | ﹤0.01% |
+44
| New | +$718 |
|
184
Alto Ingredients
ALTO
$453M
| $0 | ﹤0.01% |
+42
| New | +$292 |
|
185
iShares International Developed Real Estate ETF
IFGL
$82M
| $0 | ﹤0.01% |
1
| – | – |
|
186
Microsoft
MSFT
$2.93T
| $0 | ﹤0.01% |
+2
| New | +$430 |
|
187
Stock Yards Bancorp
SYBT
$2.39B
| – | – |
-278
| Closed | -$9K |
|
|
188
Target
TGT
$63.4B
| – | – |
-6,640
| Closed | -$1.04M |
|
|
CNR
189
Core Natural Resources Inc
CNR
$4.18B
| $0 | ﹤0.01% |
25
| – | – |
|
|
IVF
190
INVO Fertility Inc
IVF
$1.86M
| – | – |
0
| – | – |
|
|
ASXC
191
DELISTED
Asensus Surgical, Inc.
ASXC
| $0 | ﹤0.01% |
20
| – | – |
|
Similar funds
SWASL
SL
BBP
HP
MIC
WFAG
HFM
RPC
Gleason Group's Q4 2020 Portfolio in Review
As of Q4 2020, Gleason Group held 197 positions worth $208M, up 20% from $173M the previous quarter. Its ten largest holdings account for 77% of the portfolio.
Gleason Group deployed $9.53M of net new capital in Q4 2020, opening 16 new positions and adding to 101 existing holdings. Its largest new stake was Invesco QQQ Trust: 500 shares worth $157K.
By sector, the portfolio is most concentrated in Healthcare at 3.3% of assets, down from 4.1% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was Johnson & Johnson, an estimated $228K trimmed.
- Gleason Group's largest Q4 2020 buy was Invesco QQQ Trust: 500 shares worth $157K.
- Gleason Group added most to Vanguard S&P 500 ETF in Q4 2020, an estimated $2.99M increase.
- Gleason Group's biggest Q4 2020 reduction was Johnson & Johnson, cutting an estimated $228K.
- Gleason Group fully exited Target in Q4 2020, selling an estimated $1.04M.
- Gleason Group's ten largest holdings make up 77% of its $208M portfolio in Q4 2020.
- Gleason Group opened 16 new positions and closed 4 in Q4 2020.
- Gleason Group's portfolio value rose 20% quarter-over-quarter to $208M.
Based on Gleason Group's 13F filing for Q4 2020, filed 28 Jan 2021.